Cut biopsy numbers for less concerning breast findings
Part of Cancer, Skin clinical trials.
This study tests a plan meant to reduce how often people get a breast biopsy when the abnormality looks suspicious but not highly worrisome. It may help more people avoid unnecessary procedures while still keeping close medical follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re a woman (any race or ethnicity)
- You are 30 years old or older
- You have a breast abnormality that looks suspicious and your doctor scheduled an imaging-guided biopsy
- You can understand the study and agree to informed consent
- You do not have a breast implant in the breast being studied
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether getting a contrast-enhanced mammogram (CEM) every two years is effective for detecting breast cancer in women who have had breast cancer before. If you qualify, you will receive CEM instead of a standard mammogram to see if it helps find cancer earlier.
This study tests whether a special type of mammogram (contrast-enhanced mammography, or CEM) can help doctors see additional breast findings that show up on MRI. It may help avoid unnecessary extra biopsies or surgeries.
This study looks at a special breast CT scan done with a lower radiation dose to help produce clear breast images. You may be able to join if you are getting breast imaging or a biopsy for a possible breast issue and meet the safety and comfort requirements.
This study tests how well a special mammogram with contrast can help assess breast cancer risk in women with dense breast tissue. It may help improve screening planning, especially when standard mammograms are harder to read due to density.
This study uses a special type of mammogram with contrast dye to see if it can predict how well breast cancer responds to chemotherapy before surgery. It's for people with HER2-positive or triple-negative breast cancer.
This study looks at whether contrast-enhanced mammography (CEM) can find breast cancer better in women who have dense breast tissue and a personal history of breast cancer. If you've had breast cancer before and have dense breasts, this trial could help improve early detection.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.